A clinical trail to study the effects of two therapies, vamana karma & virechana karm in patients of prediabetes
Phase 3
- Conditions
- Health Condition 1: E139- Other specified diabetes mellituswithout complications
- Registration Number
- CTRI/2020/04/024777
- Lead Sponsor
- DR ANJALY PR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age not less than 30 years and not more than 50 years
2.Family H/O type II Diabetes.
3.Fasting blood sugar (glucose) level of: 100mg/dL to 125mg/dL( ADA Criteria)
4.Postprandial blood sugar (glucose)level of: 140mg/dL to 200mg/dL ( ADA Criteria)
5.HbA1c level of: 5.7% - 6.4% ( ADA Criteria)
6.BMI more than 25. (ADA criteria).
7.Subjects who are fit for Vamana & Virechana.
Exclusion Criteria
1.Subjects who are not fit for Vamana and Virechana.
2.Subjects with known type-2 Diabetes.
3.Subjects already under medication for Diabetes.
4.Subjects who are pregnant and lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method o significant difference in the outcome of both vamanakarma and virechana karmaTimepoint: For vamanakarma 9 days <br/ ><br>For virechana karma 11days
- Secondary Outcome Measures
Name Time Method Virechana karma may be better than vamana karma in pre- diabetes.Timepoint: For vamanakarma 9 days <br/ ><br>For virechana karma 11days